Research ArticleClinical Investigation
Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study
Jean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, Cyrille Touzeau, Hélène Caillon, Soraya Wuilleme, Marie-Christine Béné, Tobias Kampfenkel, Pieter Sonneveld, Mark van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Chérel, Philippe Moreau, Stéphane Minvielle and Clément Bailly
Journal of Nuclear Medicine July 2022, 63 (7) 1008-1013; DOI: https://doi.org/10.2967/jnumed.121.262884
Jean-Baptiste Alberge
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
Françoise Kraeber-Bodéré
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
3Nuclear Medicine Unit, University Hospital, Nantes, France;
4Nuclear Medicine Unit, ICO-Gauducheau, Nantes-Saint-Herblain, France;
5Haematology Department, University Hospital, Nantes, France;
Bastien Jamet
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
3Nuclear Medicine Unit, University Hospital, Nantes, France;
Cyrille Touzeau
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
5Haematology Department, University Hospital, Nantes, France;
Hélène Caillon
5Haematology Department, University Hospital, Nantes, France;
Soraya Wuilleme
5Haematology Department, University Hospital, Nantes, France;
Marie-Christine Béné
5Haematology Department, University Hospital, Nantes, France;
Tobias Kampfenkel
6Janssen Research & Development, LLC, Leiden, The Netherlands;
Pieter Sonneveld
7Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands; and
Mark van Duin
7Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands; and
Herve Avet-Loiseau
8Unité de Génomique du Myélome, Institut Universitaire du Cancer de Toulouse, Institut National de la Santé, Oncopole, Toulouse, France
Jill Corre
8Unité de Génomique du Myélome, Institut Universitaire du Cancer de Toulouse, Institut National de la Santé, Oncopole, Toulouse, France
Florence Magrangeas
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
5Haematology Department, University Hospital, Nantes, France;
Thomas Carlier
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
3Nuclear Medicine Unit, University Hospital, Nantes, France;
Caroline Bodet-Milin
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
3Nuclear Medicine Unit, University Hospital, Nantes, France;
Michel Chérel
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
4Nuclear Medicine Unit, ICO-Gauducheau, Nantes-Saint-Herblain, France;
Philippe Moreau
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
5Haematology Department, University Hospital, Nantes, France;
Stéphane Minvielle
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
5Haematology Department, University Hospital, Nantes, France;
Clément Bailly
1Université de Nantes, CHU Nantes, CNRS, Inserm, CRCINA, Nantes, France;
2Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France;
3Nuclear Medicine Unit, University Hospital, Nantes, France;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 7
July 1, 2022
Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study
Jean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, Cyrille Touzeau, Hélène Caillon, Soraya Wuilleme, Marie-Christine Béné, Tobias Kampfenkel, Pieter Sonneveld, Mark van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Chérel, Philippe Moreau, Stéphane Minvielle, Clément Bailly
Journal of Nuclear Medicine Jul 2022, 63 (7) 1008-1013; DOI: 10.2967/jnumed.121.262884
Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study
Jean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, Cyrille Touzeau, Hélène Caillon, Soraya Wuilleme, Marie-Christine Béné, Tobias Kampfenkel, Pieter Sonneveld, Mark van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Chérel, Philippe Moreau, Stéphane Minvielle, Clément Bailly
Journal of Nuclear Medicine Jul 2022, 63 (7) 1008-1013; DOI: 10.2967/jnumed.121.262884